Knobel, Demian
Scheuzger, Jonas
Buser, Andreas
Hollinger, Alexa
Gebhard, Caroline E.
Achermann, Rita
Zaiser, Anna
Bovey, Yann
Nuciforo, Chiara
Netzer, Julie Noëmie
Räber, Aline
Singh, Jasprit
Siegemund, Martin http://orcid.org/0000-0002-2013-4140
Funding for this research was provided by:
“Young Talents in Clinical Research” from the “Goldschmidt & Jacobson Foundation”
Gottfried und Julia Bangerter-Rhyner-Stiftung
Department of Anesthesiology and Pain Medicine, University of California, Davis
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
University of Basel
Article History
Received: 5 December 2021
Accepted: 5 May 2022
First Online: 3 June 2022
Declarations
:
: Martin Siegemund, MD has received speaker honoraria from Fresenius Kabi, Switzerland. The other authors declare that there are no competing interests.
: The cantonal ethics committee (Ethics committee of Northwest and Central Switzerland (EKNZ)) has approved the initial study (Reference number: EKNZ 2017-01190). Written consent and consent for publication were obtained for all participating patients or their next of kin as part of the Ba<sup>2</sup>MiTraL-trial. No further patient-measurements were necessary for this secondary analysis.